HADH Antikörper (Cy3)
Kurzübersicht für HADH Antikörper (Cy3) (ABIN702283)
Target
Alle HADH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from mouse HADHSC
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C
-
Haltbarkeit
- 12 months
-
-
- HADH (Hydroxyacyl-CoA Dehydrogenase (HADH))
-
Andere Bezeichnung
- Schad/Hadhsc
-
Hintergrund
-
HADHSC functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene.
Synonyms: HAD, HADHSC, HCDH, HHF4, M SCHAD, Medium and short chain L 3 hydroxyacyl coenzyme A dehydrogenase, SCHAD, Short chain 3 hydroxyacyl CoA dehydrogenase mitochondrial.
-
Gen-ID
- 3033
-
Pathways
- Negative Regulation of Hormone Secretion, Monocarboxylic Acid Catabolic Process
Target
-